Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index; 11 of the 32 sources its claims cite were checked for support.

Estradiol and Progesterone Regulate the Migration of Mast Cells from the Periphery to the Uterus and Induce Their Maturation and Degranulation

Open access

Abstract

BACKGROUND: Mast cells (MCs) have long been suspected as important players for implantation based on the fact that their degranulation causes the release of pivotal factors, e.g., histamine, MMPs, tryptase and VEGF, which are known to be involved in the attachment and posterior invasion of the embryo into the uterus. Moreover, MC degranulation correlates with angiogenesis during pregnancy. The number of MCs in the uterus has been shown to fluctuate during menstrual cycle in human and estrus cycle in rat and mouse indicating a hormonal influence on their recruitment from the periphery to the uterus. However, the mechanisms behind MC migration to the uterus are still unknown. METHODOLOGY/PRINCIPAL FINDINGS: We first utilized migration assays to show that MCs are able to migrate to the uterus and to the fetal-maternal interface upon up-regulation of the expression of chemokine receptors by hormonal changes. By using a model of ovariectomized animals, we provide clear evidences that also in vivo, estradiol and progesterone attract MC to the uterus and further provoke their maturation and degranulation. CONCLUSION/SIGNIFICANCE: We propose that estradiol and progesterone modulate the migration of MCs from the periphery to the uterus and their degranulation, which may prepare the uterus for implantation.

Overview

CoChat Summary

## TL;DR

This paper argues that estradiol and progesterone help recruit mast cells to the uterus and fetal-maternal interface by altering chemokine receptor expression, and also promote mast cell maturation and degranulation. In ovariectomized mice, combined E2+P4 treatment increased uterine mast cells and degranulation, with Mcpt-1, Mcpt-5, and Mcpt-8 mRNA also increased.

## Key findings

  • In transwell assays, HMC-1 mast cells migrated toward human primary first-trimester trophoblasts and JEG-3 cells; the paper reports about 40% migration after 4 h toward trophoblasts and a highest migration after 24 h toward primary trophoblasts.
  • HMC-1 cells also migrated toward E2+P4-treated AN3-CA uterine cells, with the highest migration after 24 h at 22%.
  • Hormone treatment regulated chemokine receptor expression: in HMC-1 cells, E2 at 200 and 400 pg/ml up-regulated CCR4, and 100 and 400 pg/ml up-regulated CCR5; in BMMCs, E2 and P4 up-regulated CCR3 and CCR5.
  • Female hormones promoted mast cell maturation and degranulation: E2 (200 and 400 pg/ml) and P4 (10 and 50 ng/ml) significantly induced HMC-1 degranulation, and in OVX mice E2+P4 caused a marked increase in uterine mast cells and degranulation to 50.33±9.87% (p = 0.0097), compared with vehicle-treated mice (19.3±5.17%).

## Methods

  • The study used in vitro co-culture and transwell migration assays with human mast cells (HMC-1), primary first-trimester trophoblasts, JEG-3 trophoblast cells, and AN3-CA uterine cells; it also used primary mouse bone marrow-derived mast cells (BMMCs).
  • For the in vivo component, 6-week-old ovariectomized female C57B6/J mice were treated subcutaneously for 3 consecutive days with E2 (5 µg), P4 (2.5 mg), E2+P4, or saline control (n = 5 per group).
  • Main analyses included flow cytometry for chemokine receptors, toluidine blue staining and microscopy for uterine mast cells, mast cell degranulation assay, immunofluorescence, Western blot, and real-time RT-PCR for Mcpt-1, Mcpt-5, and Mcpt-8.

## Limitations

  • The paper does not state a formal limitations section; this is not stated in the paper.
  • The in vivo experiment used a small sample size (n = 5 per group), which is evident from the methods.
  • The paper relies heavily on cell lines and ovariectomized mice, so direct generalization to normal human menstrual cycles or implantation is not directly tested in the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0014409

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 MCs and human trophoblast cells strongly interact with each other. Co-culture system between primary first trimester trophoblast cells or choriocarcinoma trophoblast cell line (JEG-3) with HMC-1 MC line (Fig. 1A–B and Fig. 1C respectively). Big adherent cells represent trophoblasts (indicated with an open arrow) whereas smaller, round cells attached to them are MCs (indicated with a closed arrow). As negative control we co-cultured a human keratinocyte cell line (HaCaT) with HMC-1 cells. Fig. 1D shows the complete absent of HMC-1 cells attached to the HaCaT cell after washing. Fig. 1E and Fig. 1G show HMC-1 CD117+ cells as stained by immunofluorescence co-cultured either with human trophoblasts or JEG-3 cells respectively. F and H pictures were done by light microscopy on the same area than Fig. E and G respectively DAPI was used as counterstaining. Fig. 1A, C, D were done with a 200× total magnification; Fig. 1B was done with a 400× total magnification and Fig. F, H were done with a 1000× total magnification under light microscopy using the Axiovision Rel 4–6 program (Zeiss AX 10 microscope). Fig. E, G were done with a 1000X total magnification by using the HXP-120 Light Source for Fluorescence Illumination and the Axiovision Rel 4–6 program (Zeiss AX 10 microscope).
Figure 1 MCs and human trophoblast cells strongly interact with each other. Co-culture system between primary first trimester trophoblast cells or choriocarcinoma trophoblast cell line (JEG-3) with HMC-1 MC line (Fig. 1A–B and Fig. 1C respectively). Big adherent cells represent trophoblasts (indicated with an open arrow) whereas smaller, round cells attached to them are MCs (indicated with a closed arrow). As negative control we co-cultured a human keratinocyte cell line (HaCaT) with HMC-1 cells. Fig. 1D shows the complete absent of HMC-1 cells attached to the HaCaT cell after washing. Fig. 1E and Fig. 1G show HMC-1 CD117+ cells as stained by immunofluorescence co-cultured either with human trophoblasts or JEG-3 cells respectively. F and H pictures were done by light microscopy on the same area than Fig. E and G respectively DAPI was used as counterstaining. Fig. 1A, C, D were done with a 200× total magnification; Fig. 1B was done with a 400× total magnification and Fig. F, H were done with a 1000× total magnification under light microscopy using the Axiovision Rel 4–6 program (Zeiss AX 10 microscope). Fig. E, G were done with a 1000X total magnification by using the HXP-120 Light Source for Fluorescence Illumination and the Axiovision Rel 4–6 program (Zeiss AX 10 microscope).CC BY · PubMed Central
Figure 2 Human MCs actively migrate towards human trophoblast cells as well as to uterine cells treated with hormones. Using a two-chamber trans-well system, the migration of HMC-1 cells to primary first trimester trophoblasts (Fig. 2A) or JEG-3 cells (Fig. 2B) as well as to uterine cell line (AN3-CA) (Fig. 2C) upon hormonal treatment was analyzed at different time points (0, 4, 8, 24, and 48 h) by determining the relative number of HMC-1-CD117+ cells present in the lower part of the system referred to the total number of CD117+ cells in the upper and lower chambers. Spontaneous migration (ca. 5%) was subtracted for all time points. Data are representative of four experiments done in duplicates each. *:p<0.05 and **:p<0.01 as analyzed by ANOVA test followed by Tukey's test.
Figure 2 Human MCs actively migrate towards human trophoblast cells as well as to uterine cells treated with hormones. Using a two-chamber trans-well system, the migration of HMC-1 cells to primary first trimester trophoblasts (Fig. 2A) or JEG-3 cells (Fig. 2B) as well as to uterine cell line (AN3-CA) (Fig. 2C) upon hormonal treatment was analyzed at different time points (0, 4, 8, 24, and 48 h) by determining the relative number of HMC-1-CD117+ cells present in the lower part of the system referred to the total number of CD117+ cells in the upper and lower chambers. Spontaneous migration (ca. 5%) was subtracted for all time points. Data are representative of four experiments done in duplicates each. *:p<0.05 and **:p<0.01 as analyzed by ANOVA test followed by Tukey's test.CC BY · PubMed Central
Figure 3 BMMCs and HMC-1 express high levels of CD117 as well as estradiol and progesterone receptors. Dot plots of cultured BMMCs (A) or HCM-1 cells (B) stained for CD117/FceRI as and CD117 as analyzed by flow cytometry. (C) BMMCs and HCM-1 cells (D) were stained with toluidine blue and they present typical features of MCs as analyzed by light microscopy using a total augmentation of 1000 X (Zeiss AX 10/Axiovision Rel 4.6). (E) and (F) represent western blots for estrogen receptor (ERα) and beta (ERβ) while (G) represent western blot for progesterone receptor (PR), respectively for HCM-1 (a) and BMMCs cells (b). β-actin served as house keeping gene.
Figure 3 BMMCs and HMC-1 express high levels of CD117 as well as estradiol and progesterone receptors. Dot plots of cultured BMMCs (A) or HCM-1 cells (B) stained for CD117/FceRI as and CD117 as analyzed by flow cytometry. (C) BMMCs and HCM-1 cells (D) were stained with toluidine blue and they present typical features of MCs as analyzed by light microscopy using a total augmentation of 1000 X (Zeiss AX 10/Axiovision Rel 4.6). (E) and (F) represent western blots for estrogen receptor (ERα) and beta (ERβ) while (G) represent western blot for progesterone receptor (PR), respectively for HCM-1 (a) and BMMCs cells (b). β-actin served as house keeping gene.CC BY · PubMed Central
Figure 4 Estradiol and progesterone treatment in vitro results in the up-regulation of chemokine receptors in MCs. A–B: Chemokine receptor expression CCR4 (A) or CCR5 (B) on HMC-1 cells treated for 1 h with different physiological concentrations of estradiol (E2). E2 significantly up-regulated the expression of CCR4 and CCR5 in HMC-1 cells. C-D: Chemokine receptor expression CCR4 (C) or CCR5 (D) on HMC-1 cells treated for 1 h with a combination of E2P4. E2P4 treatment induced a significant up-regulation of both, CCR4 and CCR5 on HMC-1. E–H: Chemokine receptor expression CCR3 (E and G) or CCR5 (F and H) on BMMCs treated for 1 h with different physiological concentrations of E2 (E and F) or progesterone (P4; G and H). Both hormones induced an up-regulation of CCR3 (E, G) and CCR5 (F, H) in BMMCs after 1 h of treatment. I–J: Chemokine receptor expression CCR3 (I) or CCR5 (J) on BMMCs treated for 1 h with E2P4. Treatment of BMMCs with a combination of both hormones induced a significant increment on the expression of CCR3 and CCR5. The data are representative of four experiments performed in duplicates or triplicates. Chemokine receptor expression was analyzed by flow cytometry and data are expressed as percentage of cells expressing the chemokine receptors analyzed as mean ± S.E.M. *:p<0.05 as analyzed by ANOVA test followed by Tukey's test (A–B, E–H). The Mann-Whitney-U test for two particular groups was used (C–D, I–J). In all cases the expression of chemokines receptors for each dose vs. control was compared. K: BMMCs migration toward CCL5 (3 hours) is expressed as percentage of cells that migrated towards the CCL5 gradient from the total amount of cells. Spontaneous migration was subtracted. The data are representative of three experiments and are expressed as means ± S.E.M. *:p<0.05, **: p<0.01 and ***: p<0.001 as analyzed by the Mann-Whitney-U test.
Figure 4 Estradiol and progesterone treatment in vitro results in the up-regulation of chemokine receptors in MCs. A–B: Chemokine receptor expression CCR4 (A) or CCR5 (B) on HMC-1 cells treated for 1 h with different physiological concentrations of estradiol (E2). E2 significantly up-regulated the expression of CCR4 and CCR5 in HMC-1 cells. C-D: Chemokine receptor expression CCR4 (C) or CCR5 (D) on HMC-1 cells treated for 1 h with a combination of E2P4. E2P4 treatment induced a significant up-regulation of both, CCR4 and CCR5 on HMC-1. E–H: Chemokine receptor expression CCR3 (E and G) or CCR5 (F and H) on BMMCs treated for 1 h with different physiological concentrations of E2 (E and F) or progesterone (P4; G and H). Both hormones induced an up-regulation of CCR3 (E, G) and CCR5 (F, H) in BMMCs after 1 h of treatment. I–J: Chemokine receptor expression CCR3 (I) or CCR5 (J) on BMMCs treated for 1 h with E2P4. Treatment of BMMCs with a combination of both hormones induced a significant increment on the expression of CCR3 and CCR5. The data are representative of four experiments performed in duplicates or triplicates. Chemokine receptor expression was analyzed by flow cytometry and data are expressed as percentage of cells expressing the chemokine receptors analyzed as mean ± S.E.M. *:p<0.05 as analyzed by ANOVA test followed by Tukey's test (A–B, E–H). The Mann-Whitney-U test for two particular groups was used (C–D, I–J). In all cases the expression of chemokines receptors for each dose vs. control was compared. K: BMMCs migration toward CCL5 (3 hours) is expressed as percentage of cells that migrated towards the CCL5 gradient from the total amount of cells. Spontaneous migration was subtracted. The data are representative of three experiments and are expressed as means ± S.E.M. *:p<0.05, **: p<0.01 and ***: p<0.001 as analyzed by the Mann-Whitney-U test.CC BY · PubMed Central
Figure 5 Estradiol and progesterone treatment in vitro as well as their combined application up-regulate the expression of human tryptase in HMC-1 cells. Human mast cell tryptase expression on HMC-1 cells treated for 1 h either with estradiol (E2; A), progesterone (P4; B) or (E2 + P4; C) was analyzed by Western Blot using GAPDH as house keeping gene. Physiological concentrations of both estradiol (A) and progesterone (B) corresponding to their concentrations towards middle menstrual cycle or just after ovulation takes place respectively as well as the combination of both hormones at their most effective concentration, significantly up-regulated the expression of human tryptase on HMC-1 cells (C). Data are expressed as Tryptase/GAPDH ratio (mean ± S.E.M.) *:p<0.05 as analyzed by ANOVA test followed by Tukey's test (A–B) or The Kruskall-Wallis test followed by Mann-Whitney-U test (C). Each experiment was done in triplicate; the blots are representative from three independent experiments. Tryptase expression in HMC-1 cells after hormonal treatment was compared to the controls in each case.
Figure 5 Estradiol and progesterone treatment in vitro as well as their combined application up-regulate the expression of human tryptase in HMC-1 cells. Human mast cell tryptase expression on HMC-1 cells treated for 1 h either with estradiol (E2; A), progesterone (P4; B) or (E2 + P4; C) was analyzed by Western Blot using GAPDH as house keeping gene. Physiological concentrations of both estradiol (A) and progesterone (B) corresponding to their concentrations towards middle menstrual cycle or just after ovulation takes place respectively as well as the combination of both hormones at their most effective concentration, significantly up-regulated the expression of human tryptase on HMC-1 cells (C). Data are expressed as Tryptase/GAPDH ratio (mean ± S.E.M.) *:p<0.05 as analyzed by ANOVA test followed by Tukey's test (A–B) or The Kruskall-Wallis test followed by Mann-Whitney-U test (C). Each experiment was done in triplicate; the blots are representative from three independent experiments. Tryptase expression in HMC-1 cells after hormonal treatment was compared to the controls in each case.CC BY · PubMed Central
Figure 6 Estradiol and progesterone as well as a estradiol-progesterone combined treatment induce in vitro HMC-1 degranulation. Physiological concentrations of both, estradiol (E2; A) and progesterone (P4; B) significantly induced HMC-1 degranulation after 1 h of treatment as analyzed by measuring chromophore p-nitroaniline (pNA) produced after cleavage from the labeled substrate tosyl-gly-pro-lys-pNA by tryptase present in the supernatant of HCM-1 cells employing a MC-degranulation kit. (C) shows the degranulation observed after in vitro application of both, estradiol and progesterone. Positive controls included the treatment of HMC-1 cells with calcium ionophore to induce degranulation while negative controls were cells treated with calcium ionophore plus protamine inhibitor. Data are expressed as mean ± S.E.M of the optical density at 405 nm as measured in the supernatant of treated cells. *:p<0.05, **:p<0.01 and ***:p<0.001 as analyzed by ANOVA test followed by Tukey's test. Each experiment was done in triplicate.
Figure 6 Estradiol and progesterone as well as a estradiol-progesterone combined treatment induce in vitro HMC-1 degranulation. Physiological concentrations of both, estradiol (E2; A) and progesterone (P4; B) significantly induced HMC-1 degranulation after 1 h of treatment as analyzed by measuring chromophore p-nitroaniline (pNA) produced after cleavage from the labeled substrate tosyl-gly-pro-lys-pNA by tryptase present in the supernatant of HCM-1 cells employing a MC-degranulation kit. (C) shows the degranulation observed after in vitro application of both, estradiol and progesterone. Positive controls included the treatment of HMC-1 cells with calcium ionophore to induce degranulation while negative controls were cells treated with calcium ionophore plus protamine inhibitor. Data are expressed as mean ± S.E.M of the optical density at 405 nm as measured in the supernatant of treated cells. *:p<0.05, **:p<0.01 and ***:p<0.001 as analyzed by ANOVA test followed by Tukey's test. Each experiment was done in triplicate.CC BY · PubMed Central
Figure 7 Female hormones induce the migration of MCs to the uterus, their maturation and degranulation Virgin ovariectomized C57BL/6J mice were treated with estradiol (E2), progesterone (P4) or estradiol + progesterone (E2 + P4). The number of MCs was quantified in 10 fields of uterine tissue from all animals (n = 5/group). MC visualization was performed by tolouidine blue staining and quantification was done using a total magnification of 1000 X under light microscopy using the Axiovision Rel 4–6 program (Zeiss AX 10 microscope). E2 alone or in combination with P4 induced a significantly augmentation in the number of uterine MCs as compared to the vehicle-treated animals (A). Representative pictures from uterine MCs from control (B), E2-treated (C), P4-treated (D) and E2 + P4- treated animals (E) are shown. Arrows indicate uterine MCs, which are easily distinguishable because of their granula. F-H: show the expression of MC-related genes Mcpt-1 (F), Mcpt-5 (G) and Mcpt-8 (H) in uterus of treated and control animals as analyzed by real time RT-PCR. The results are expressed as single dots showing medians. *:p<0.05 and **:p<0.01 as analyzed by Kruskall-Wallis test followed by Mann-Whitney-U test for two particular groups.
Figure 7 Female hormones induce the migration of MCs to the uterus, their maturation and degranulation Virgin ovariectomized C57BL/6J mice were treated with estradiol (E2), progesterone (P4) or estradiol + progesterone (E2 + P4). The number of MCs was quantified in 10 fields of uterine tissue from all animals (n = 5/group). MC visualization was performed by tolouidine blue staining and quantification was done using a total magnification of 1000 X under light microscopy using the Axiovision Rel 4–6 program (Zeiss AX 10 microscope). E2 alone or in combination with P4 induced a significantly augmentation in the number of uterine MCs as compared to the vehicle-treated animals (A). Representative pictures from uterine MCs from control (B), E2-treated (C), P4-treated (D) and E2 + P4- treated animals (E) are shown. Arrows indicate uterine MCs, which are easily distinguishable because of their granula. F-H: show the expression of MC-related genes Mcpt-1 (F), Mcpt-5 (G) and Mcpt-8 (H) in uterus of treated and control animals as analyzed by real time RT-PCR. The results are expressed as single dots showing medians. *:p<0.05 and **:p<0.01 as analyzed by Kruskall-Wallis test followed by Mann-Whitney-U test for two particular groups.CC BY · PubMed Central

Verification

Claims the paper makes

9 Valid · 0 Not valid · 15 Not checked · 40 Own results and interpretations

29 more claims

Create a free account to see all 64 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 15

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 3

  1. JF Nelson, 1981, Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice., Biol Reprod, 24, 784, 10.1095/biolreprod24.4.784 · DOI · Paper page
  2. J Zhang, 1998, Mast cell regulation of human endometrial matrix metalloproteinases: A mechanism underlying menstruation., Biol Reprod, 59, 693, 10.1095/biolreprod59.3.693 · DOI · Paper page
  3. M Lees, 1994, Mast cell proteinases activate precursor forms of collagenase and stromelysin 1, but not of gelatineases A and B., Eur J Biochem, 1;223, 171, 10.1111/j.1432-1033.1994.tb18980.x · DOI · Paper page

Cited by

See all 145

Metadata

Authors
Jensen, F., Woudwyk, M., Teles, A., Woidacki, K., Taran, F., Costa, S., Malfertheiner, S. F., & Zenclussen, A. C.
Affiliations
  • Otto-von-Guericke-Universität Magdeburg (DE)
  • Universidad Nacional de La Plata (AR)
  • Centro de Neurociências e Biologia Celular (PT)
Corresponding author
  • Jensen, Federico
  • Zenclussen, Ana Claudia
Venue
PLoS ONE
Published
2010-12-22
Volume
5
Issue
12
Pages
e14409
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2100080480
Cited by
145
References
53
Citations by year
2026: 7 · 2025: 15 · 2024: 10 · 2023: 10 · 2022: 11 · 2021: 8 · 2020: 8 · 2019: 13 · 2018: 8 · 2017: 10 · 2016: 5 · 2015: 14 · 2014: 6 · 2013: 11 · 2012: 6
FWCI
2.75
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Americanae (AECID Library) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Estudo Geral (Universidad de Coimbra) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Funders
Deutsche Forschungsgemeinschaft (ZE 526/6-1, SPP 1394, SFB-854, SFB 854 TP7)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
mast cells, estradiol, progesterone, mast cell migration, mast cell degranulation, mast cell maturation, implantation, chemokine receptors, ovariectomy, pregnancy, angiogenesis, maternal-fetal interface, hormonal regulation
MeSH terms
Animals, Cell Movement, Estradiol, Estrus, Female, Humans, Mast Cells, Pregnancy, Progesterone, Trophoblasts, Uterus, Cell Degranulation, Neovascularization, Physiologic, Chemokines, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estradiol and Progesterone Regulate the Migration of Mast Cells from the Periphery to the Uterus and Induce Their Maturation and Degranulation. https://app.cochat.ai/papers/10.1371/journal.pone.0014409
The paper
Jensen, F., Woudwyk, M., Teles, A., Woidacki, K., Taran, F., Costa, S., Malfertheiner, S. F., & Zenclussen, A. C. (2010). Estradiol and Progesterone Regulate the Migration of Mast Cells from the Periphery to the Uterus and Induce Their Maturation and Degranulation. PLoS ONE. https://doi.org/10.1371/journal.pone.0014409

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.